Combined trastuzumab and paclitaxel treatment better inhibits ErbB-2-mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone (Q44595949)
Jump to navigation
Jump to search
scientific article published in October 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined trastuzumab and paclitaxel treatment better inhibits ErbB-2-mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone |
scientific article published in October 2003 |
Statements
1 reference
Combined trastuzumab and paclitaxel treatment better inhibits ErbB-2-mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone (English)
1 reference
Kristine S Klos
1 reference
Xiaoyan Zhou
1 reference
Sangkyou Lee
1 reference
Lianglin Zhang
1 reference
Wentao Yang
1 reference
Yoichi Nagata
1 reference
Dihua Yu
1 reference
1 October 2003
1 reference
Identifiers
1 reference